Reliance Chemotex closes trading window from Oct 1 ahead of Q2FY27 results
- Trading window closes on October 1, 2026, for insiders and connected persons
- Restriction lasts until 48 hours after Q2FY27 results announcement
- Closure complies with SEBI (Prohibition of Insider Trading) Regulations, 2015
- Results cover the quarter and half-year ending September 30, 2026

*this image is generated using AI for illustrative purposes only.
Reliance Chemotex Industries Ltd announced the closure of its trading window for dealing in securities, effective October 1, 2026. This measure is in anticipation of the company's upcoming financial results for the second quarter of fiscal year 2027.
The trading window will remain closed for Directors, Promoters, Designated Persons, Connected Persons, and their immediate relatives. The restriction applies from October 1, 2026, until 48 hours after the declaration or announcement of the Un-audited Financial Results.
Regulatory Compliance and Timeline
The closure is implemented pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, and the Company's internal Code of Prohibition of Insider Trading. The results pertain to the quarter and half-year ending September 30, 2026.
| Event | Date/Duration |
|---|---|
| Trading Window Closure Start | October 1, 2026 |
| Trading Window Reopening | 48 hours after Q2FY27 results announcement |
| Reporting Period | Quarter and half-year ending September 30, 2026 |
| Intimation Date | September 25, 2026 |
The communication was issued to both BSE Limited and National Stock Exchange of India Ltd. Chandrasekaran Rajagopalan, CFO cum Company Secretary and Compliance Officer, signed the intimation on behalf of the company.
Historical Stock Returns for Reliance Chemotex
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.81% | +0.13% | +5.32% | +7.81% | -24.99% | -47.41% |
How might the Q2FY27 financial results influence Reliance Chemotex's stock volatility once the trading window reopens?
What specific operational or macroeconomic factors are analysts expecting to drive Reliance Chemotex's performance for the quarter ending September 2026?
Could the upcoming results reveal significant changes in the company's debt profile or capital expenditure plans that may impact future investor sentiment?


































